| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR | California State Teachers Retirement System | Institution | 173,379 | Added More | 100 | 0.05 % | $2,942,242 | $2,942,242 | $0 | 0.00 % | $0 | | | | | | News Article | History of California State Teachers Retirement System Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Ing Investment Management Europe B V | Institution | 53,239 | Sold Some | -31,014 | -36.81 % | $903,466 | $903,466 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ing Investment Management Europe B V Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-20 | 2009-09-30 | N-Q | Rs Investment Trust - Rs Smaller Company Growth Fund | Small-Cap Growth | 49,600 | Sold Some | -7,970 | -13.84 % | $841,712 | $841,712 | $0 | 0.00 % | $0 | | | | | | News Article | History of Rs Investment Trust - Rs Smaller Company Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-20 | 2009-09-30 | N-Q | Sit Mutual Funds Inc - Sit Small Cap Growth Fund | Mid-Cap Growth | 13,700 | No Change | 0 | 0 % | $232,489 | $232,489 | $0 | 0.00 % | $0 | | | | | | News Article | History of Sit Mutual Funds Inc - Sit Small Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR/A | Adage Capital Partners Gp Llc | Institution | | Sold All | -500,000 | -100 % | | | | -2.13 % | $185,000 | | | | | | News Article | History of Adage Capital Partners Gp Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Royal Bank Of Canada Trust Co Ltd | Institution | 47 | No Change | 0 | 0 % | $815 | $798 | $-17 | -2.13 % | $0 | | | | | | News Article | History of Royal Bank Of Canada Trust Co Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Timber Hill Llc | No Data | 36,769 | New Holding | 36,769 | 100 % | $637,574 | $623,970 | $-13,605 | -2.13 % | $-13,605 | | | | | | News Article | History of Timber Hill Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 2,523,565 | Added More | 40,442 | 1.62 % | $43,203,433 | $42,824,898 | $-378,535 | -0.87 % | $-6,066 | | | | | | News Article | History of Amvescap Plc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 84,765 | Added More | 47,257 | 125.99 % | $1,451,177 | $1,438,462 | $-12,715 | -0.87 % | $-7,089 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 260,775 | Sold Some | -336,455 | -56.33 % | $4,464,468 | $4,425,352 | $-39,116 | -0.87 % | $50,468 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | 1798 Global Partners Ltd | Institution | | Sold All | -12,800 | -100 % | | | | 0.65 % | $-1,408 | | | | | | News Article | History of 1798 Global Partners Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Accipiter Capital Management Llc | Institution | 401,471 | Added More | 6,000 | 1.51 % | $6,768,801 | $6,812,963 | $44,162 | 0.65 % | $660 | | | | | | News Article | History of Accipiter Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Altrinsic Global Advisors Llc | Institution | 2,493,952 | Added More | 982,722 | 65.02 % | $42,048,031 | $42,322,365 | $274,335 | 0.65 % | $108,099 | | | | | | News Article | History of Altrinsic Global Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 1,983 | Sold Some | -64,153 | -97.00 % | $33,433 | $33,652 | $218 | 0.65 % | $-7,057 | | | | | | News Article | History of American International Group Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 14,200 | New Holding | 14,200 | 100 % | $239,412 | $240,974 | $1,562 | 0.65 % | $1,562 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Management Llc | No Data | 2,748 | Sold Some | -10,602 | -79.41 % | $46,331 | $46,634 | $302 | 0.65 % | $-1,166 | | | | | | News Article | History of Bam Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Offshore Management Llc | No Data | | Sold All | -50,000 | -100 % | | | | 0.65 % | $-5,500 | | | | | | News Article | History of Bam Offshore Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capstone Investment Advisors Llc | Institution | 14,734 | New Holding | 14,734 | 100 % | $248,415 | $250,036 | $1,621 | 0.65 % | $1,621 | | | | | | News Article | History of Capstone Investment Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 536,746 | Added More | 535,856 | 60208.53 % | $9,049,538 | $9,108,580 | $59,042 | 0.65 % | $58,944 | | | | | | News Article | History of Citadel L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Clough Capital Partners L P | Institution | 42,300 | Added More | 4,300 | 11.31 % | $713,178 | $717,831 | $4,653 | 0.65 % | $473 | | | | | | News Article | History of Clough Capital Partners L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 17,300 | No Change | 0 | 0 % | $291,678 | $293,581 | $1,903 | 0.65 % | $0 | | | | | | News Article | History of Eaton Vance Management Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | | Sold All | -5,077 | -100 % | | | | 0.65 % | $-558 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 3,017,284 | Sold Some | -1,911,407 | -38.78 % | $50,871,408 | $51,203,309 | $331,901 | 0.65 % | $-210,255 | | | | | | News Article | History of Fmr Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 50,000 | Added More | 5,000 | 11.11 % | $843,000 | $848,500 | $5,500 | 0.65 % | $550 | | | | | | News Article | History of Galleon Management L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Healthcor Management L P | Institution | 4,900,000 | Added More | 1,500,000 | 44.11 % | $82,614,000 | $83,153,000 | $539,000 | 0.65 % | $165,000 | | | | | | News Article | History of Healthcor Management L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 423,274 | Added More | 11,724 | 2.84 % | $7,136,400 | $7,182,960 | $46,560 | 0.65 % | $1,290 | | | | | | News Article | History of Ing Groep Nv Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Jesaga Advisers Llc | Institution | 33,200 | Sold Some | -1,900 | -5.41 % | $559,752 | $563,404 | $3,652 | 0.65 % | $-209 | | | | | | News Article | History of Jesaga Advisers Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Mackenzie Financial Corp | Institution | 197,300 | Added More | 1,000 | 0.50 % | $3,326,478 | $3,348,181 | $21,703 | 0.65 % | $110 | | | | | | News Article | History of Mackenzie Financial Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Mazama Capital Management Inc | Institution | 119,250 | Sold Some | -445 | -0.37 % | $2,010,555 | $2,023,673 | $13,118 | 0.65 % | $-49 | | | | | | News Article | History of Mazama Capital Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 1,764,485 | Sold Some | -3,085,431 | -63.61 % | $29,749,217 | $29,943,310 | $194,093 | 0.65 % | $-339,397 | | | | | | News Article | History of Millennium Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Moore Capital Management Lp | Institution | 200,000 | New Holding | 200,000 | 100 % | $3,372,000 | $3,394,000 | $22,000 | 0.65 % | $22,000 | | | | | | News Article | History of Moore Capital Management Lp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 271,409 | Sold Some | -119,297 | -30.53 % | $4,575,956 | $4,605,811 | $29,855 | 0.65 % | $-13,123 | | | | | | News Article | History of Morgan Stanley Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Noonday Asset Management L P | Institution | 228,000 | No Change | 0 | 0 % | $3,844,080 | $3,869,160 | $25,080 | 0.65 % | $0 | | | | | | News Article | History of Noonday Asset Management L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | | Sold All | -166,957 | -100 % | | | | 0.65 % | $-18,365 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 390,864 | Added More | 6,904 | 1.79 % | $6,589,967 | $6,632,962 | $42,995 | 0.65 % | $759 | | | | | | News Article | History of Northern Trust Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 2,800 | Added More | 400 | 16.66 % | $47,208 | $47,516 | $308 | 0.65 % | $44 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Orbimed Advisors Llc | Institution | 3,108,800 | Sold Some | -495,100 | -13.73 % | $52,414,368 | $52,756,336 | $341,968 | 0.65 % | $-54,461 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Palo Alto Investors Llc | Institution | 1,133,538 | Added More | 3,130 | 0.27 % | $19,111,451 | $19,236,140 | $124,689 | 0.65 % | $344 | | | | | | News Article | History of Palo Alto Investors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Porter Orlin Llc | Institution | 880,263 | Added More | 267,000 | 43.53 % | $14,841,234 | $14,938,063 | $96,829 | 0.65 % | $29,370 | | | | | | News Article | History of Porter Orlin Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rbc Dominion Securities Inc | Institution | 800 | No Change | 0 | 0 % | $13,488 | $13,576 | $88 | 0.65 % | $0 | | | | | | News Article | History of Rbc Dominion Securities Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ridgeback Capital Investments Lp | Institution | 600,000 | New Holding | 600,000 | 100 % | $10,116,000 | $10,182,000 | $66,000 | 0.65 % | $66,000 | | | | | | News Article | History of Ridgeback Capital Investments Lp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rockefeller Financial Services Inc | Institution | 611,040 | Added More | 9,900 | 1.64 % | $10,302,134 | $10,369,349 | $67,214 | 0.65 % | $1,089 | | | | | | News Article | History of Rockefeller Financial Services Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 50,000 | New Holding | 50,000 | 100 % | $843,000 | $848,500 | $5,500 | 0.65 % | $5,500 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 1,673,823 | Added More | 1,508,071 | 909.83 % | $28,220,656 | $28,404,776 | $184,121 | 0.65 % | $165,888 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Thales Fund Management Llc | Institution | 21,554 | New Holding | 21,554 | 100 % | $363,400 | $365,771 | $2,371 | 0.65 % | $2,371 | | | | | | News Article | History of Thales Fund Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 12,020 | Sold Some | -62,284 | -83.82 % | $202,657 | $203,979 | $1,322 | 0.65 % | $-6,851 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 1,293,964 | Added More | 35,727 | 2.83 % | $21,816,233 | $21,958,569 | $142,336 | 0.65 % | $3,930 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 76 | Sold Some | -326 | -81.09 % | $1,281 | $1,290 | $8 | 0.65 % | $-36 | | | | | | News Article | History of Us Bancorp De Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weintraub Capital Management Lp | Institution | 150,000 | Sold Some | -300,000 | -66.66 % | $2,529,000 | $2,545,500 | $16,500 | 0.65 % | $-33,000 | | | | | | News Article | History of Weintraub Capital Management Lp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 145,000 | Added More | 10,000 | 7.40 % | $2,444,700 | $2,460,650 | $15,950 | 0.65 % | $1,100 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 521,100 | Sold Some | -122,600 | -19.04 % | $8,785,746 | $8,843,067 | $57,321 | 0.65 % | $-13,486 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-11-13 | 13F-HR | Wilmington Trust Fsb | Institution | 15,000 | No Change | 0 | 0 % | $247,950 | $254,550 | $6,600 | 2.66 % | $0 | | | | | | News Article | History of Wilmington Trust Fsb Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 1,190,803 | Sold Some | -40,492 | -3.28 % | $19,683,974 | $20,207,927 | $523,953 | 2.66 % | $-17,816 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ascend Capital Llc | Institution | 380,000 | New Holding | 380,000 | 100 % | $6,281,400 | $6,448,600 | $167,200 | 2.66 % | $167,200 | | | | | | News Article | History of Ascend Capital Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 570,391 | Sold Some | -39,101 | -6.41 % | $9,428,563 | $9,679,535 | $250,972 | 2.66 % | $-17,204 | | | | | | News Article | History of Axa Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 67,964 | Sold Some | -94,442 | -58.15 % | $1,123,445 | $1,153,349 | $29,904 | 2.66 % | $-41,554 | | | | | | News Article | History of Barclays Plc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 21,933 | Added More | 759 | 3.58 % | $362,552 | $372,203 | $9,651 | 2.66 % | $334 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 62,889 | New Holding | 62,889 | 100 % | $1,039,555 | $1,067,226 | $27,671 | 2.66 % | $27,671 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Cramer Rosenthal Mcglynn Llc | Institution | 2,977,469 | New Holding | 2,977,469 | 100 % | $49,217,563 | $50,527,649 | $1,310,086 | 2.66 % | $1,310,086 | | | | | | News Article | History of Cramer Rosenthal Mcglynn Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 2,350 | New Holding | 2,350 | 100 % | $38,846 | $39,880 | $1,034 | 2.66 % | $1,034 | | | | | | News Article | History of Credit Agricole S A Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 170,000 | No Change | 0 | 0 % | $2,810,100 | $2,884,900 | $74,800 | 2.66 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | 16,600 | Sold Some | -163,000 | -90.75 % | $274,398 | $281,702 | $7,304 | 2.66 % | $-71,720 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Mercantile Trust Co | Institution | 25,500 | No Change | 0 | 0 % | $421,515 | $432,735 | $11,220 | 2.66 % | $0 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Friess Associates Llc | Institution | | Sold All | -4,488,000 | -100 % | | | | 2.66 % | $-1,974,720 | | | | | | News Article | History of Friess Associates Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 230,111 | Added More | 6,020 | 2.68 % | $3,803,735 | $3,904,984 | $101,249 | 2.66 % | $2,649 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 330,953 | Sold Some | -152,008 | -31.47 % | $5,470,653 | $5,616,272 | $145,619 | 2.66 % | $-66,884 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | 131,000 | New Holding | 131,000 | 100 % | $2,165,430 | $2,223,070 | $57,640 | 2.66 % | $57,640 | | | | | | News Article | History of Hambrecht And Quist Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jefferies Group Inc | Institution | 66,571 | New Holding | 66,571 | 100 % | $1,100,419 | $1,129,710 | $29,291 | 2.66 % | $29,291 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jennison Associates Llc | Institution | 1,349,200 | Added More | 95,200 | 7.59 % | $22,302,276 | $22,895,924 | $593,648 | 2.66 % | $41,888 | | | | | | News Article | History of Jennison Associates Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -15,007 | -100 % | | | | 2.66 % | $-6,603 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Investment Counsel Llc | Institution | 445,984 | Added More | 33,279 | 8.06 % | $7,372,116 | $7,568,348 | $196,233 | 2.66 % | $14,643 | | | | | | News Article | History of Legg Mason Investment Counsel Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Trust Company National Association | Institution | 150,647 | No Change | 0 | 0 % | $2,490,195 | $2,556,480 | $66,285 | 2.66 % | $0 | | | | | | News Article | History of Legg Mason Trust Company National Association Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Lord Abbett And Co Llc | Institution | 217,000 | No Change | 0 | 0 % | $3,587,010 | $3,682,490 | $95,480 | 2.66 % | $0 | | | | | | News Article | History of Lord Abbett And Co Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 46,455 | Added More | 35,971 | 343.10 % | $767,901 | $788,341 | $20,440 | 2.66 % | $15,827 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Managers Amg Funds - Timessquare Small Cap Growth Fund | Small-Cap Growth | 305,000 | Added More | 10,000 | 3.38 % | $5,041,650 | $5,175,850 | $134,200 | 2.66 % | $4,400 | | | | | | News Article | History of Managers Amg Funds - Timessquare Small Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | | Sold All | -16,100 | -100 % | | | | 2.66 % | $-7,084 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Lazard Mid Cap Portfolio | Mid-Cap Core | 191,000 | No Change | 0 | 0 % | $3,157,230 | $3,241,270 | $84,040 | 2.66 % | $0 | | | | | | News Article | History of Met Investors Series Trust - Lazard Mid Cap Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Metaim Small Cap Growth Portfolio | Small-Cap Growth | 386,720 | Added More | 9,894 | 2.62 % | $6,392,482 | $6,562,638 | $170,157 | 2.66 % | $4,353 | | | | | | News Article | History of Met Investors Series Trust - Metaim Small Cap Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Munder Capital Management | Institution | 4,448,294 | Added More | 318,339 | 7.70 % | $73,530,300 | $75,487,549 | $1,957,249 | 2.66 % | $140,069 | | | | | | News Article | History of Munder Capital Management Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 104,500 | No Change | 0 | 0 % | $1,727,385 | $1,773,365 | $45,980 | 2.66 % | $0 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 2,600 | No Change | 0 | 0 % | $42,978 | $44,122 | $1,144 | 2.66 % | $0 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Polar Capital Llp | Institution | | Sold All | -40,000 | -100 % | | | | 2.66 % | $-17,600 | | | | | | News Article | History of Polar Capital Llp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 8,152,590 | Sold Some | -3,900 | -0.04 % | $134,762,313 | $138,349,452 | $3,587,140 | 2.66 % | $-1,716 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 304 | New Holding | 304 | 100 % | $5,025 | $5,159 | $134 | 2.66 % | $134 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sentinel Asset Management Inc | Institution | 50,300 | No Change | 0 | 0 % | $831,459 | $853,591 | $22,132 | 2.66 % | $0 | | | | | | News Article | History of Sentinel Asset Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Soundpost Partners Lp | Institution | | Sold All | -100,000 | -100 % | | | | 2.66 % | $-44,000 | | | | | | News Article | History of Soundpost Partners Lp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Suttonbrook Capital Management Lp | Institution | 1,000,000 | New Holding | 1,000,000 | 100 % | $16,530,000 | $16,970,000 | $440,000 | 2.66 % | $440,000 | | | | | | News Article | History of Suttonbrook Capital Management Lp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 3,876,304 | Added More | 113,338 | 3.01 % | $64,075,305 | $65,780,879 | $1,705,574 | 2.66 % | $49,869 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | 168,800 | Sold Some | -15,200 | -8.26 % | $2,813,896 | $2,864,536 | $50,640 | 1.79 % | $-4,560 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 1,595,648 | Added More | 118,505 | 8.02 % | $26,599,452 | $27,078,147 | $478,694 | 1.79 % | $35,552 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 1,044,258 | Sold Some | -109,202 | -9.46 % | $17,407,781 | $17,721,058 | $313,277 | 1.79 % | $-32,761 | | | | | | News Article | History of Bank Of America Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 3,735,446 | Added More | 130,782 | 3.62 % | $62,269,885 | $63,390,519 | $1,120,634 | 1.79 % | $39,235 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 3,735,446 | Sold Some | -118,880 | -3.08 % | $62,269,885 | $63,390,519 | $1,120,634 | 1.79 % | $-35,664 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Blackthorn Investment Group Llc | Institution | 45,000 | Sold Some | -5,000 | -10.00 % | $750,150 | $763,650 | $13,500 | 1.79 % | $-1,500 | | | | | | News Article | History of Blackthorn Investment Group Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Columbia Wanger Asset Management Lp | Institution | 4,745,576 | Added More | 361,890 | 8.25 % | $79,108,752 | $80,532,425 | $1,423,673 | 1.79 % | $108,567 | | | | | | News Article | History of Columbia Wanger Asset Management Lp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Corestates Capital Advisors Llc | No Data | 46 | No Change | 0 | 0 % | $767 | $781 | $14 | 1.79 % | $0 | | | | | | News Article | History of Corestates Capital Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 70,608 | New Holding | 70,608 | 100 % | $1,177,035 | $1,198,218 | $21,182 | 1.79 % | $21,182 | | | | | | News Article | History of Credit Suisse Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson D A And Co | Institution | 241 | No Change | 0 | 0 % | $4,017 | $4,090 | $72 | 1.79 % | $0 | | | | | | News Article | History of Davidson D A And Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson Investment Advisors | Institution | 241 | New Holding | 241 | 100 % | $4,017 | $4,090 | $72 | 1.79 % | $72 | | | | | | News Article | History of Davidson Investment Advisors Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | | Sold All | -340,000 | -100 % | | | | 1.79 % | $-102,000 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Engemann Asset Management | Institution | 41,451 | Added More | 282 | 0.68 % | $690,988 | $703,423 | $12,435 | 1.79 % | $85 | | | | | | News Article | History of Engemann Asset Management Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Quadrant L P | Institution | 200 | No Change | 0 | 0 % | $3,334 | $3,394 | $60 | 1.79 % | $0 | | | | | | News Article | History of First Quadrant L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 91,404 | No Change | 0 | 0 % | $1,523,705 | $1,551,126 | $27,421 | 1.79 % | $0 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 3,097,870 | Sold Some | -390,177 | -11.18 % | $51,641,493 | $52,570,854 | $929,361 | 1.79 % | $-117,053 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Great West Life Assurance Co | Institution | 25,100 | Added More | 600 | 2.44 % | $418,417 | $425,947 | $7,530 | 1.79 % | $180 | | | | | | News Article | History of Great West Life Assurance Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Gsa Capital Partners Llp | Institution | | Sold All | -10,931 | -100 % | | | | 1.79 % | $-3,279 | | | | | | News Article | History of Gsa Capital Partners Llp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 122,450 | Added More | 38,400 | 45.68 % | $2,041,242 | $2,077,977 | $36,735 | 1.79 % | $11,520 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 19,639 | Sold Some | -36,609 | -65.08 % | $327,382 | $333,274 | $5,892 | 1.79 % | $-10,983 | | | | | | News Article | History of Kbc Group Nv Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | N-Q | M Fund Inc - Frontier Capital Appreciation Fund | Specialty & Misc | 38,700 | Sold Some | -2,100 | -5.14 % | $645,129 | $656,739 | $11,610 | 1.79 % | $-630 | | | | | | News Article | History of M Fund Inc - Frontier Capital Appreciation Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | N-Q | Meridian Fund Inc - Meridian Value Fund | Mid-Cap Core | 658,700 | New Holding | 658,700 | 100 % | $10,980,529 | $11,178,139 | $197,610 | 1.79 % | $197,610 | | | | | | News Article | History of Meridian Fund Inc - Meridian Value Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 45,435 | Sold Some | -249,240 | -84.58 % | $757,401 | $771,032 | $13,631 | 1.79 % | $-74,772 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 13,531 | Added More | 534 | 4.10 % | $225,562 | $229,621 | $4,059 | 1.79 % | $160 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mycio Wealth Partners Llc | Institution | | Sold All | -15 | -100 % | | | | 1.79 % | $-5 | | | | | | News Article | History of Mycio Wealth Partners Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 1,163,306 | Added More | 159,806 | 15.92 % | $19,392,311 | $19,741,303 | $348,992 | 1.79 % | $47,942 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 55,642 | Added More | 7,341 | 15.19 % | $927,552 | $944,245 | $16,693 | 1.79 % | $2,202 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 281,048 | Added More | 73,800 | 35.60 % | $4,685,070 | $4,769,385 | $84,314 | 1.79 % | $22,140 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Primecap Management Co | Institution | 8,738,614 | Added More | 223,700 | 2.62 % | $145,672,695 | $148,294,280 | $2,621,584 | 1.79 % | $67,110 | | | | | | News Article | History of Primecap Management Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Redmile Group Llc | Institution | 147,200 | New Holding | 147,200 | 100 % | $2,453,824 | $2,497,984 | $44,160 | 1.79 % | $44,160 | | | | | | News Article | History of Redmile Group Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rice Hall James And Associates Llc | Institution | 27,212 | No Change | 0 | 0 % | $453,624 | $461,788 | $8,164 | 1.79 % | $0 | | | | | | News Article | History of Rice Hall James And Associates Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rs Investment Management Co Llc | Institution | 595,022 | New Holding | 595,022 | 100 % | $9,919,017 | $10,097,523 | $178,507 | 1.79 % | $178,507 | | | | | | News Article | History of Rs Investment Management Co Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sands Capital Management Llc | Institution | 247,300 | Added More | 3,600 | 1.47 % | $4,122,491 | $4,196,681 | $74,190 | 1.79 % | $1,080 | | | | | | News Article | History of Sands Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Santa Fe Partners Llc | Institution | 10,473 | New Holding | 10,473 | 100 % | $174,585 | $177,727 | $3,142 | 1.79 % | $3,142 | | | | | | News Article | History of Santa Fe Partners Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sector Gamma Asa | No Data | 255,000 | No Compare | | | $4,250,850 | $4,327,350 | $76,500 | 1.79 % | | | | | | | News Article | History of Sector Gamma Asa Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sovereign Asset Management Corp | Institution | 284,336 | Sold Some | -1,802 | -0.62 % | $4,739,881 | $4,825,182 | $85,301 | 1.79 % | $-541 | | | | | | News Article | History of Sovereign Asset Management Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Stafford Asset Management Llc | No Data | 12,700 | New Holding | 12,700 | 100 % | $211,709 | $215,519 | $3,810 | 1.79 % | $3,810 | | | | | | News Article | History of Stafford Asset Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 100,346 | Added More | 82,362 | 457.97 % | $1,672,768 | $1,702,872 | $30,104 | 1.79 % | $24,709 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | 10,800 | Sold Some | -97,100 | -89.99 % | $180,036 | $183,276 | $3,240 | 1.79 % | $-29,130 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Timessquare Capital Management Llc | Institution | 1,616,250 | Sold Some | -700 | -0.04 % | $26,942,888 | $27,427,763 | $484,875 | 1.79 % | $-210 | | | | | | News Article | History of Timessquare Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Welch Capital Partners Llc | Institution | 105,950 | No Change | 0 | 0 % | $1,766,187 | $1,797,972 | $31,785 | 1.79 % | $0 | | | | | | News Article | History of Welch Capital Partners Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 12,923 | No Change | 0 | 0 % | $215,426 | $219,303 | $3,877 | 1.79 % | $0 | | | | | | News Article | History of World Asset Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Zweig Dimenna Partners L P | Institution | 125,000 | New Holding | 125,000 | 100 % | $2,083,750 | $2,121,250 | $37,500 | 1.79 % | $37,500 | | | | | | News Article | History of Zweig Dimenna Partners L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | | Sold All | -114,896 | -100 % | | | | 1.98 % | $-37,916 | | | | | | News Article | History of Citigroup Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 78,347 | Added More | 11,969 | 18.03 % | $1,303,694 | $1,329,549 | $25,855 | 1.98 % | $3,950 | | | | | | News Article | History of Comerica Bank Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | First National Trust Co | Institution | 298 | Sold Some | -48 | -13.87 % | $4,959 | $5,057 | $98 | 1.98 % | $-16 | | | | | | News Article | History of First National Trust Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 16,800 | No Change | 0 | 0 % | $279,552 | $285,096 | $5,544 | 1.98 % | $0 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Highbridge Capital Management Llc | Institution | 225,065 | Sold Some | -142,938 | -38.84 % | $3,745,082 | $3,819,353 | $74,271 | 1.98 % | $-47,170 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 1,697,421 | Added More | 1,014,468 | 148.54 % | $28,245,085 | $28,805,234 | $560,149 | 1.98 % | $334,774 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Platte River Capital Llc | Institution | | Sold All | -70,290 | -100 % | | | | 1.98 % | $-23,196 | | | | | | News Article | History of Platte River Capital Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Royce And Associates Llc | Institution | 9,200 | No Change | 0 | 0 % | $153,088 | $156,124 | $3,036 | 1.98 % | $0 | | | | | | News Article | History of Royce And Associates Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Sectoral Asset Management Inc | Institution | 5,800,746 | Sold Some | -26,438 | -0.45 % | $96,524,413 | $98,438,660 | $1,914,246 | 1.98 % | $-8,725 | | | | | | News Article | History of Sectoral Asset Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Stephens Inc | Institution | 67,920 | Added More | 1,400 | 2.10 % | $1,130,189 | $1,152,602 | $22,414 | 1.98 % | $462 | | | | | | News Article | History of Stephens Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 294,070 | Sold Some | -164,851 | -35.92 % | $4,893,325 | $4,990,368 | $97,043 | 1.98 % | $-54,401 | | | | | | News Article | History of Ubs Ag Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Wisconsin Capital Management Llc | Institution | 11,800 | No Change | 0 | 0 % | $196,352 | $200,246 | $3,894 | 1.98 % | $0 | | | | | | News Article | History of Wisconsin Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Aberdeen Asset Management Plc | Institution | 48,901 | New Holding | 48,901 | 100 % | $815,180 | $829,850 | $14,670 | 1.79 % | $14,670 | | | | | | News Article | History of Aberdeen Asset Management Plc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Chartwell Investment Partners | Institution | 740,247 | Added More | 62,307 | 9.19 % | $12,339,917 | $12,561,992 | $222,074 | 1.79 % | $18,692 | | | | | | News Article | History of Chartwell Investment Partners Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Fan Asset Management Llc | Institution | 14,200 | Added More | 2,200 | 18.33 % | $236,714 | $240,974 | $4,260 | 1.79 % | $660 | | | | | | News Article | History of Fan Asset Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 3,845,273 | Added More | 10,700 | 0.27 % | $64,100,701 | $65,254,283 | $1,153,582 | 1.79 % | $3,210 | | | | | | News Article | History of Federated Investors Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lee Munder Capital Group Llc | No Data | 110,682 | No Compare | | | $1,845,069 | $1,878,274 | $33,205 | 1.79 % | | | | | | | News Article | History of Lee Munder Capital Group Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | State Of Wisconsin Investment Board | Institution | 82,819 | Added More | 8,160 | 10.92 % | $1,380,593 | $1,405,438 | $24,846 | 1.79 % | $2,448 | | | | | | News Article | History of State Of Wisconsin Investment Board Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Blair William And Co | Institution | 201,040 | Sold Some | -8,730 | -4.16 % | $3,317,160 | $3,411,649 | $94,489 | 2.84 % | $-4,103 | | | | | | News Article | History of Blair William And Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Integral Capital Management Vii Llc | Institution | 400,000 | No Change | 0 | 0 % | $6,600,000 | $6,788,000 | $188,000 | 2.84 % | $0 | | | | | | News Article | History of Integral Capital Management Vii Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Integral Capital Management Viii Llc | Institution | 225,000 | No Change | 0 | 0 % | $3,712,500 | $3,818,250 | $105,750 | 2.84 % | $0 | | | | | | News Article | History of Integral Capital Management Viii Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metlife Securities Inc | Institution | 400 | No Change | 0 | 0 % | $6,600 | $6,788 | $188 | 2.84 % | $0 | | | | | | News Article | History of Metlife Securities Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pioneer Investment Management Inc | Institution | 370,000 | Added More | 77,300 | 26.40 % | $6,105,000 | $6,278,900 | $173,900 | 2.84 % | $36,331 | | | | | | News Article | History of Pioneer Investment Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 63 | Sold Some | -1,602 | -96.21 % | $1,040 | $1,069 | $30 | 2.84 % | $-753 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Provident Investment Counsel | Institution | 197,763 | Sold Some | -27,525 | -12.21 % | $3,263,090 | $3,356,038 | $92,949 | 2.84 % | $-12,937 | | | | | | News Article | History of Provident Investment Counsel Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 29,600 | Sold Some | -15,700 | -34.65 % | $488,400 | $502,312 | $13,912 | 2.84 % | $-7,379 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 36,443 | No Change | 0 | 0 % | $601,310 | $618,438 | $17,128 | 2.84 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 532,098 | Sold Some | -15,700 | -2.86 % | $8,779,617 | $9,029,703 | $250,086 | 2.84 % | $-7,379 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Trilogy Global Advisors Llc | Institution | | Sold All | -53,800 | -100 % | | | | 2.84 % | $-25,286 | | | | | | News Article | History of Trilogy Global Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Weatherbie M A And Co Inc | Institution | 868,436 | Sold Some | -11,725 | -1.33 % | $14,329,194 | $14,737,359 | $408,165 | 2.84 % | $-5,511 | | | | | | News Article | History of Weatherbie M A And Co Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Aster Investment Management Co Inc | Institution | 658,700 | New Holding | 658,700 | 100 % | $10,736,810 | $11,178,139 | $441,329 | 4.11 % | $441,329 | | | | | | News Article | History of Aster Investment Management Co Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | N-Q | Crm Mutual Fund Trust - Crm All Cap Value Fund | Multi-Cap Value | 8,200 | No Change | 0 | 0 % | $133,660 | $139,154 | $5,494 | 4.11 % | $0 | | | | | | News Article | History of Crm Mutual Fund Trust - Crm All Cap Value Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | N-Q | Crm Mutual Fund Trust - Crm Mid Cap Value Fund | Mid-Cap Value | 334,300 | Added More | 61,500 | 22.54 % | $5,449,090 | $5,673,071 | $223,981 | 4.11 % | $41,205 | | | | | | News Article | History of Crm Mutual Fund Trust - Crm Mid Cap Value Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | N-Q | Crm Mutual Fund Trust - Crm Small Cap Value Fund | Small-Cap Value | 522,300 | Added More | 45,200 | 9.47 % | $8,513,490 | $8,863,431 | $349,941 | 4.11 % | $30,284 | | | | | | News Article | History of Crm Mutual Fund Trust - Crm Small Cap Value Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Mitsubishi Ufj Asset Management Co Ltd | No Data | 1,500 | No Change | 0 | 0 % | $24,450 | $25,455 | $1,005 | 4.11 % | $0 | | | | | | News Article | History of Mitsubishi Ufj Asset Management Co Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 12,120 | Sold Some | -5,600 | -31.60 % | $197,556 | $205,676 | $8,120 | 4.11 % | $-3,752 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 35,106 | Added More | 1,599 | 4.77 % | $572,228 | $595,749 | $23,521 | 4.11 % | $1,071 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 11,052 | Sold Some | -394 | -3.44 % | $180,148 | $187,552 | $7,405 | 4.11 % | $-264 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Teacher Retirement System Of Texas | Institution | 149,380 | Added More | 2,980 | 2.03 % | $2,434,894 | $2,534,979 | $100,085 | 4.11 % | $1,997 | | | | | | News Article | History of Teacher Retirement System Of Texas Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Fort Washington Investment Advisors Inc | Institution | 472,148 | Added More | 27,112 | 6.09 % | $7,422,167 | $8,012,352 | $590,185 | 7.95 % | $33,890 | | | | | | News Article | History of Fort Washington Investment Advisors Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Frontier Capital Management Co Inc | Institution | 447,900 | Sold Some | -900 | -0.20 % | $7,040,988 | $7,600,863 | $559,875 | 7.95 % | $-1,125 | | | | | | News Article | History of Frontier Capital Management Co Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 72,000 | No Change | 0 | 0 % | $1,131,840 | $1,221,840 | $90,000 | 7.95 % | $0 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Symphony Asset Management Llc | Institution | 21,546 | New Holding | 21,546 | 100 % | $338,703 | $365,636 | $26,933 | 7.95 % | $26,933 | | | | | | News Article | History of Symphony Asset Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Ixis Asset Management Advisors L P | Institution | 35,724 | Sold Some | -2,387 | -6.26 % | $569,083 | $606,236 | $37,153 | 6.52 % | $-2,482 | | | | | | News Article | History of Ixis Asset Management Advisors L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | M And T Bank Corp | Institution | 59,425 | Added More | 9,115 | 18.11 % | $946,640 | $1,008,442 | $61,802 | 6.52 % | $9,480 | | | | | | News Article | History of M And T Bank Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Private Trust Co Na | Institution | | Sold All | -35 | -100 % | | | | 6.52 % | $-36 | | | | | | News Article | History of Private Trust Co Na Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 49,550 | New Holding | 49,550 | 100 % | $789,332 | $840,864 | $51,532 | 6.52 % | $51,532 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Ghp Investment Advisors Inc | Institution | 1,500 | No Change | 0 | 0 % | $23,340 | $25,455 | $2,115 | 9.06 % | $0 | | | | | | News Article | History of Ghp Investment Advisors Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Thrivent Financial For Lutherans | Institution | 923,976 | Sold Some | -747,176 | -44.71 % | $14,377,067 | $15,679,873 | $1,302,806 | 9.06 % | $-1,053,518 | | | | | | News Article | History of Thrivent Financial For Lutherans Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Health Care Portfolio | Health/Biotech | 723,185 | No Change | 0 | 0 % | $11,252,759 | $12,272,449 | $1,019,691 | 9.06 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Health Care Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 40,600 | Sold Some | -2,000 | -4.69 % | $631,736 | $688,982 | $57,246 | 9.06 % | $-2,820 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 1,582,778 | New Holding | 1,582,778 | 100 % | $24,628,026 | $26,859,743 | $2,231,717 | 9.06 % | $2,231,717 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Mainstream Investment Advisers Llc | Institution | 15,365 | Sold Some | -1,800 | -10.48 % | $239,079 | $260,744 | $21,665 | 9.06 % | $-2,538 | | | | | | News Article | History of Mainstream Investment Advisers Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | | Sold All | -40,599 | -100 % | | | | 9.06 % | $-57,245 | | | | | | News Article | History of Oxford Asset Management Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Sit Investment Associates Inc | Institution | 61,450 | Sold Some | -800 | -1.28 % | $956,162 | $1,042,807 | $86,645 | 9.06 % | $-1,128 | | | | | | News Article | History of Sit Investment Associates Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 4,041 | No Compare | | | $62,878 | $68,576 | $5,698 | 9.06 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund | Multi-Cap Growth | | Sold All | -3,744,500 | -100 % | | | | 9.06 % | $-5,279,745 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Jennison Sector Funds Inc - Jennison Health Sciences Fund | Health/Biotech | 1,002,200 | New Holding | 1,002,200 | 100 % | $15,594,232 | $17,007,334 | $1,413,102 | 9.06 % | $1,413,102 | | | | | | News Article | History of Jennison Sector Funds Inc - Jennison Health Sciences Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Lord Abbett Research Fund Inc - Americas Value Fund | Multi-Cap Value | 200 | New Holding | 200 | 100 % | $3,112 | $3,394 | $282 | 9.06 % | $282 | | | | | | News Article | History of Lord Abbett Research Fund Inc - Americas Value Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Lord Abbett Research Fund Inc - Growth Opportunities Fund | Mid-Cap Growth | | Sold All | -57,522 | -100 % | | | | 9.06 % | $-81,106 | | | | | | News Article | History of Lord Abbett Research Fund Inc - Growth Opportunities Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Mercantile Funds Inc - Mercantile Capital Opportunities Fund | Specialty & Misc | | Sold All | -3,500 | -100 % | | | | 9.06 % | $-4,935 | | | | | | News Article | History of Mercantile Funds Inc - Mercantile Capital Opportunities Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Professionally Managed Portfolios - Stephens Small Cap Growth Fund | Small-Cap Growth | 7,600 | Added More | 700 | 10.14 % | $118,256 | $128,972 | $10,716 | 9.06 % | $987 | | | | | | News Article | History of Professionally Managed Portfolios - Stephens Small Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 45,617 | New Holding | 45,617 | 100 % | $709,801 | $774,120 | $64,320 | 9.06 % | $64,320 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 140,169 | Sold Some | -1,450 | -1.02 % | $2,171,218 | $2,378,668 | $207,450 | 9.55 % | $-2,146 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Growth Fund | Multi-Cap Growth | 8,962 | Sold Some | -782 | -8.02 % | $138,821 | $152,085 | $13,264 | 9.55 % | $-1,157 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Riversource Equity Series Inc - Riversource Mid Cap Growth Fund | Mid-Cap Growth | 425,653 | New Holding | 425,653 | 100 % | $6,593,365 | $7,223,331 | $629,966 | 9.55 % | $629,966 | | | | | | News Article | History of Riversource Equity Series Inc - Riversource Mid Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -100 | -100 % | | | | 9.55 % | $-148 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 143,900 | No Change | 0 | 0 % | $2,229,011 | $2,441,983 | $212,972 | 9.55 % | $0 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Fund | Small-Cap Core | 7,400 | New Holding | 7,400 | 100 % | $114,626 | $125,578 | $10,952 | 9.55 % | $10,952 | | | | | | News Article | History of Valic Co I - Small Cap Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Quotient Investors Llc | No Data | 13,600 | New Holding | 13,600 | 100 % | $213,248 | $230,792 | $17,544 | 8.22 % | $17,544 | | | | | | News Article | History of Quotient Investors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Dws Securities Trust - Dws Health Care Fund | Health/Biotech | 137,000 | Added More | 34,900 | 34.18 % | $2,148,160 | $2,324,890 | $176,730 | 8.22 % | $45,021 | | | | | | News Article | History of Dws Securities Trust - Dws Health Care Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Essex Investment Management Co Llc | Institution | 169,501 | Added More | 121,670 | 254.37 % | $2,845,922 | $2,876,432 | $30,510 | 1.07 % | $21,901 | | | | | | News Article | History of Essex Investment Management Co Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Holland Capital Management L P | Institution | 119,550 | No Change | 0 | 0 % | $2,007,245 | $2,028,764 | $21,519 | 1.07 % | $0 | | | | | | News Article | History of Holland Capital Management L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Sterling Johnston Capital Management Lp | Institution | 377,450 | Added More | 63,450 | 20.20 % | $6,337,386 | $6,405,327 | $67,941 | 1.07 % | $11,421 | | | | | | News Article | History of Sterling Johnston Capital Management Lp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | High Pointe Capital Management Llc | Institution | 24,700 | No Change | 0 | 0 % | $411,502 | $419,159 | $7,657 | 1.86 % | $0 | | | | | | News Article | History of High Pointe Capital Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 52 | No Change | 0 | 0 % | $866 | $882 | $16 | 1.86 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-26 | 2009-08-31 | N-CSR | Eaton Vance Growth Trust - Eaton Vance Worldwide Health Sciences Fund | Health/Biotech | | Sold All | -1,200,000 | -100 % | | | | 1.86 % | $-372,000 | | | | | | News Article | History of Eaton Vance Growth Trust - Eaton Vance Worldwide Health Sciences Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-26 | 2009-08-31 | N-CSR | Worldwide Health Sciences Portfolio - Worldwide Health Sciences | Health/Biotech | | Sold All | -1,200,000 | -100 % | | | | 1.86 % | $-372,000 | | | | | | News Article | History of Worldwide Health Sciences Portfolio - Worldwide Health Sciences Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 1,231,295 | Added More | 215,203 | 21.17 % | $20,513,375 | $20,895,076 | $381,701 | 1.86 % | $66,713 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Columbus Circle Investors | Institution | 510,072 | New Holding | 510,072 | 100 % | $8,671,224 | $8,655,922 | $-15,302 | -0.17 % | $-15,302 | | | | | | News Article | History of Columbus Circle Investors Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Crown Capital Management | Institution | 50,000 | Sold Some | -25,000 | -33.33 % | $850,000 | $848,500 | $-1,500 | -0.17 % | $750 | | | | | | News Article | History of Crown Capital Management Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 753,337 | Sold Some | -177,500 | -19.06 % | $12,844,396 | $12,784,129 | $-60,267 | -0.46 % | $14,200 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 193,372 | Added More | 73,600 | 61.45 % | $3,296,993 | $3,281,523 | $-15,470 | -0.46 % | $-5,888 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 230,892 | Sold Some | -24,629 | -9.63 % | $3,936,709 | $3,918,237 | $-18,471 | -0.46 % | $1,970 | | | | | | News Article | History of Blackrock Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 133,745 | Added More | 19,298 | 16.86 % | $2,280,352 | $2,269,653 | $-10,700 | -0.46 % | $-1,544 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Eagle Asset Management Inc | Institution | 1,711,917 | Added More | 91,403 | 5.64 % | $29,188,185 | $29,051,231 | $-136,953 | -0.46 % | $-7,312 | | | | | | News Article | History of Eagle Asset Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Merrill Lynch Mercury Asset Management Japan Ltd | Institution | | Sold All | -1,400 | -100 % | | | | -0.46 % | $112 | | | | | | News Article | History of Merrill Lynch Mercury Asset Management Japan Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Regions Financial Corp | Institution | 21,723 | Sold Some | -170 | -0.77 % | $370,377 | $368,639 | $-1,738 | -0.46 % | $14 | | | | | | News Article | History of Regions Financial Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 425,965 | Sold Some | -40,029 | -8.59 % | $7,198,809 | $7,228,626 | $29,818 | 0.41 % | $-2,802 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 326,649 | Added More | 42,330 | 14.88 % | $5,520,368 | $5,543,234 | $22,865 | 0.41 % | $2,963 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Tokio Marine Asset Management Usa Ltd | Institution | 96,800 | No Change | 0 | 0 % | $1,635,920 | $1,642,696 | $6,776 | 0.41 % | $0 | | | | | | News Article | History of Tokio Marine Asset Management Usa Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 107,300 | No Change | 0 | 0 % | $1,777,961 | $1,820,881 | $42,920 | 2.41 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 141,629 | No Change | 0 | 0 % | $2,407,693 | $2,403,444 | $-4,249 | -0.17 % | $0 | | | | | | News Article | History of Strs Ohio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Nordea Investment Management Ab | Institution | 200,300 | Added More | 69,016 | 52.57 % | $3,557,328 | $3,399,091 | $-158,237 | -4.44 % | $-54,523 | | | | | | News Article | History of Nordea Investment Management Ab Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 176,011 | Added More | 27,000 | 18.11 % | $3,125,955 | $2,986,907 | $-139,049 | -4.44 % | $-21,330 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Friedberg Investment Management | Institution | 385 | No Change | 0 | 0 % | $6,741 | $6,533 | $-208 | -3.08 % | $0 | | | | | | News Article | History of Friedberg Investment Management Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Granahan Investment Management Inc | Institution | 1,210,900 | No Change | 0 | 0 % | $21,202,859 | $20,548,973 | $-653,886 | -3.08 % | $0 | | | | | | News Article | History of Granahan Investment Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | World Funds Trust - Commonwealth Small Cap Fund | No Data | 475 | New Holding | 475 | 100 % | $8,298 | $8,061 | $-238 | -2.86 % | $-238 | | | | | | News Article | History of World Funds Trust - Commonwealth Small Cap Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 109,785 | Added More | 7,632 | 7.47 % | $1,914,650 | $1,863,051 | $-51,599 | -2.69 % | $-3,587 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-08 | 2008-07-31 | N-CSR | Morgan Stanley Health Sciences Trust - None | Specialty & Misc | 100,000 | Sold Some | -67,500 | -40.29 % | $1,744,000 | $1,697,000 | $-47,000 | -2.69 % | $31,725 | | | | | | News Article | History of Morgan Stanley Health Sciences Trust - None Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 170,652 | Added More | 57,526 | 50.85 % | $3,029,073 | $2,895,964 | $-133,109 | -4.39 % | $-44,870 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund | Health/Biotech | 385,534 | Added More | 186,667 | 93.86 % | $6,843,229 | $6,542,512 | $-300,717 | -4.39 % | $-145,600 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Fidelity Devonshire Trust - Fidelity Series All-Sector Equity Fund | No Data | | Sold All | -55,010 | -100 % | | | | -4.39 % | $42,908 | | | | | | News Article | History of Fidelity Devonshire Trust - Fidelity Series All-Sector Equity Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Legg Mason Partners Equity Trust - Legg Mason Partners Social Awareness Fund | Specialty & Misc | 109,297 | New Holding | 109,297 | 100 % | $1,940,022 | $1,854,770 | $-85,252 | -4.39 % | $-85,252 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Social Awareness Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Health Care Ultrasector Profund | Health/Biotech | 438 | Added More | 234 | 114.70 % | $7,775 | $7,433 | $-342 | -4.39 % | $-183 | | | | | | News Article | History of Profunds - Health Care Ultrasector Profund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Natcan Investment Management Inc | Institution | 12,300 | No Change | 0 | 0 % | $215,619 | $208,731 | $-6,888 | -3.19 % | $0 | | | | | | News Article | History of Natcan Investment Management Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Money Market Fund | Specialty & Misc | | Sold All | -24,400 | -100 % | | | | -2.41 % | $10,248 | | | | | | News Article | History of Usaa Mutual Funds Trust - Money Market Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Aim Investment Funds - Aim Developing Markets Fund | Emerging Markets | 799,695 | New Holding | 799,695 | 100 % | $14,658,409 | $13,570,824 | $-1,087,585 | -7.41 % | $-1,087,585 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 61,519 | Added More | 14,551 | 30.98 % | $1,127,643 | $1,043,977 | $-83,666 | -7.41 % | $-19,789 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 5,900 | No Change | 0 | 0 % | $108,147 | $100,123 | $-8,024 | -7.41 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | | Sold All | -900 | -100 % | | | | -7.41 % | $1,224 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dws Balanced Fund - Dws Balanced Fund | Flexible Portfolio | 9,400 | Sold Some | -1,500 | -13.76 % | $172,302 | $159,518 | $-12,784 | -7.41 % | $2,040 | | | | | | News Article | History of Dws Balanced Fund - Dws Balanced Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dws Globalinternational Fund Inc - Dws Global Opportunities Fund | Global Flex Port | 81,200 | Sold Some | -4,900 | -5.69 % | $1,488,396 | $1,377,964 | $-110,432 | -7.41 % | $6,664 | | | | | | News Article | History of Dws Globalinternational Fund Inc - Dws Global Opportunities Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Evergreen Equity Trust De - Evergreen Health Care Fund | Health/Biotech | 108,236 | New Holding | 108,236 | 100 % | $1,983,966 | $1,836,765 | $-147,201 | -7.41 % | $-147,201 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Health Care Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Capital Trust - Fidelity Capital Appreciation Fund | Specialty & Misc | | Sold All | -398,105 | -100 % | | | | -7.41 % | $541,423 | | | | | | News Article | History of Fidelity Capital Trust - Fidelity Capital Appreciation Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Mid Cap Stock Fund | Mid-Cap Core | 1,250,000 | Added More | 250,000 | 25.00 % | $22,912,500 | $21,212,500 | $-1,700,000 | -7.41 % | $-340,000 | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Mid Cap Stock Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - Small Cap Growth Opportunities Fund | Small-Cap Growth | 75,758 | New Holding | 75,758 | 100 % | $1,388,644 | $1,285,613 | $-103,031 | -7.41 % | $-103,031 | | | | | | News Article | History of First American Investment Funds Inc - Small Cap Growth Opportunities Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Heritage Series Trust - Diversified Growth Fund | Multi-Cap Growth | 226,875 | Sold Some | -2,650 | -1.15 % | $4,158,619 | $3,850,069 | $-308,550 | -7.41 % | $3,604 | | | | | | News Article | History of Heritage Series Trust - Diversified Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Mid Growth Index Fund | Mid-Cap Growth | | Sold All | -32,586 | -100 % | | | | -7.41 % | $44,317 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Mid Growth Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Small Growth Index Fund | Small-Cap Growth | 32,994 | New Holding | 32,994 | 100 % | $604,780 | $559,908 | $-44,872 | -7.41 % | $-44,872 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Small Growth Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Managers Trust I - Managers Small Cap Fund | Small-Cap Core | 29,800 | Sold Some | -1,900 | -5.99 % | $546,234 | $505,706 | $-40,528 | -7.41 % | $2,584 | | | | | | News Article | History of Managers Trust I - Managers Small Cap Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Riversource International Managers Series Inc - Riversource International Aggressive Growth Fund | International Multi-Cap Growth | 30,000 | Added More | 8,714 | 40.93 % | $549,900 | $509,100 | $-40,800 | -7.41 % | $-11,851 | | | | | | News Article | History of Riversource International Managers Series Inc - Riversource International Aggressive Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Seligman Frontier Fund Inc - Seligman Frontier Fund Inc | Small-Cap Growth | 26,600 | New Holding | 26,600 | 100 % | $487,578 | $451,402 | $-36,176 | -7.41 % | $-36,176 | | | | | | News Article | History of Seligman Frontier Fund Inc - Seligman Frontier Fund Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | 1,264,719 | Added More | 461,500 | 57.45 % | $23,182,299 | $21,462,281 | $-1,720,018 | -7.41 % | $-627,640 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Advisors Inner Circle Fund - Fma Small Company Portfolio | Small-Cap Core | | Sold All | -100,400 | -100 % | | | | -6.70 % | $122,488 | | | | | | News Article | History of Advisors Inner Circle Fund - Fma Small Company Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Jpmorgan Trust I - Jpmorgan Market Neutral Fund | Specialty & Misc | | Sold All | -18 | -100 % | | | | -6.70 % | $22 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Market Neutral Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Social Awareness Portfolio | Specialty & Misc | | Sold All | -31,480 | -100 % | | | | -6.70 % | $38,406 | | | | | | News Article | History of Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Social Awareness Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 13,300 | No Change | 0 | 0 % | $241,927 | $225,701 | $-16,226 | -6.70 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio | No Data | 2,264 | Added More | 141 | 6.64 % | $41,182 | $38,420 | $-2,762 | -6.70 % | $-172 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Balanced Fund | Mixed-Asset Target Allocation Growth | | Sold All | -1,200 | -100 % | | | | -5.24 % | $1,128 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Balanced Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Multi Cap Growth Fund | Multi-Cap Core | 875 | Added More | 25 | 2.94 % | $15,671 | $14,849 | $-823 | -5.24 % | $-24 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Multi Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Small Cap Growth Fund | Small-Cap Growth | 47,000 | Added More | 28,000 | 147.36 % | $841,770 | $797,590 | $-44,180 | -5.24 % | $-26,320 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Small Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Sunamerica Focused Series Inc - Focused Technology Portfolio | Science & Tech | 49,825 | Added More | 13,375 | 36.69 % | $892,366 | $845,530 | $-46,836 | -5.24 % | $-12,573 | | | | | | News Article | History of Sunamerica Focused Series Inc - Focused Technology Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 56,248 | Sold Some | -77,357 | -57.89 % | $1,007,402 | $954,529 | $-52,873 | -5.24 % | $72,716 | | | | | | News Article | History of Kbc Group Nv Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Primecap Odyssey Funds - Primecap Odyssey Aggressive Growth Fund | Mid-Cap Growth | 390,300 | New Holding | 390,300 | 100 % | $6,947,340 | $6,623,391 | $-323,949 | -4.66 % | $-323,949 | | | | | | News Article | History of Primecap Odyssey Funds - Primecap Odyssey Aggressive Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Primecap Odyssey Funds - Primecap Odyssey Growth Fund | Multi-Cap Core | 274,900 | New Holding | 274,900 | 100 % | $4,893,220 | $4,665,053 | $-228,167 | -4.66 % | $-228,167 | | | | | | News Article | History of Primecap Odyssey Funds - Primecap Odyssey Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds - Health Care Fund | Health/Biotech | 23,560 | Sold Some | -390 | -1.62 % | $420,075 | $399,813 | $-20,262 | -4.82 % | $335 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds - Health Care Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 17,300 | New Holding | 17,300 | 100 % | $314,168 | $293,581 | $-20,587 | -6.55 % | $-20,587 | | | | | | News Article | History of Eaton Vance Management Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-17 | 2009-06-30 | 13F-HR/A | Delaware Management Business Trust | Institution | 179,600 | Added More | 49,000 | 37.51 % | $3,290,272 | $3,047,812 | $-242,460 | -7.36 % | $-66,150 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 3,854,326 | Added More | 268,422 | 7.48 % | $67,257,989 | $65,407,912 | $-1,850,076 | -2.75 % | $-128,843 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 3,604,664 | Added More | 18,760 | 0.52 % | $62,901,387 | $61,171,148 | $-1,730,239 | -2.75 % | $-9,005 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-10 | 2009-06-30 | 13F-HR/A | Veritable L P | Institution | | Sold All | -12,590 | -100 % | | | | -2.19 % | $4,784 | | | | | | News Article | History of Veritable L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-10 | 2009-03-31 | 13F-HR/A | Veritable L P | Institution | 12,590 | New Holding | 12,590 | 100 % | $218,437 | $213,652 | $-4,784 | -2.19 % | $-4,784 | | | | | | News Article | History of Veritable L P Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Premier Growth Fund Inc - Value Line Premier Growth Fund Inc | Large-Cap Growth | | Sold All | -8,400 | -100 % | | | | 3.22 % | $-4,452 | | | | | | News Article | History of Value Line Premier Growth Fund Inc - Value Line Premier Growth Fund Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Strategic Asset Management Trust - Value Line Strategic Asset Management Trust | Multi-Cap Value | | Sold All | -29,000 | -100 % | | | | 3.22 % | $-15,370 | | | | | | News Article | History of Value Line Strategic Asset Management Trust - Value Line Strategic Asset Management Trust Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Allianz Variable Insurance Products Trust - Azl Occ Opportunity Fund | Specialty & Misc | 230,318 | Added More | 23,525 | 11.37 % | $3,721,939 | $3,908,496 | $186,558 | 5.01 % | $19,055 | | | | | | News Article | History of Allianz Variable Insurance Products Trust - Azl Occ Opportunity Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Sma Relationship Trust - Series A | Specialty & Misc | | Sold All | -2,100 | -100 % | | | | 5.01 % | $-1,701 | | | | | | News Article | History of Sma Relationship Trust - Series A Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Federated Aggressive Growth Portfolio | Multi-Cap Growth | 123,500 | Added More | 18,700 | 17.84 % | $1,985,880 | $2,095,795 | $109,915 | 5.53 % | $16,643 | | | | | | News Article | History of Advanced Series Trust - Ast Federated Aggressive Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Global Allocation Portfolio | Global Flex Port | | Sold All | -5,500 | -100 % | | | | 5.53 % | $-4,895 | | | | | | News Article | History of Advanced Series Trust - Ast Global Allocation Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 148,856 | Sold Some | -60,420 | -28.87 % | $2,393,604 | $2,526,086 | $132,482 | 5.53 % | $-53,774 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 96,800 | Added More | 46,000 | 90.55 % | $1,556,544 | $1,642,696 | $86,152 | 5.53 % | $40,940 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqinternational Growth Portfolio | Multi-Cap Growth | 22,571 | No Change | 0 | 0 % | $362,942 | $383,030 | $20,088 | 5.53 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqinternational Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Forward Funds - Forward Legato Fund | Small-Cap Core | | Sold All | -32,303 | -100 % | | | | 5.53 % | $-28,750 | | | | | | News Article | History of Forward Funds - Forward Legato Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Japan Fund | Japanese | | Sold All | -6 | -100 % | | | | 5.53 % | $-5 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Japan Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Intrepid Mid Cap Fund | Mid-Cap Core | | Sold All | -41 | -100 % | | | | 5.53 % | $-36 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Intrepid Mid Cap Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Biotechnology | Health/Biotech | 5,994 | New Holding | 5,994 | 100 % | $96,384 | $101,718 | $5,335 | 5.53 % | $5,335 | | | | | | News Article | History of Profunds - Profund Vp Biotechnology Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Health Care | Health/Biotech | 3,024 | New Holding | 3,024 | 100 % | $48,626 | $51,317 | $2,691 | 5.53 % | $2,691 | | | | | | News Article | History of Profunds - Profund Vp Health Care Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Aim Small Cap Growth Fund | No Data | 7,496 | Added More | 3,531 | 89.05 % | $120,536 | $127,207 | $6,671 | 5.53 % | $3,143 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Aim Small Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Small Company Growth Portfolio | Small-Cap Growth | 184,500 | New Holding | 184,500 | 100 % | $2,966,760 | $3,130,965 | $164,205 | 5.53 % | $164,205 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Small Company Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-04 | 2009-06-10 | N-CSRS | Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Intrepid Mid Cap Portfolio | Mid-Cap Core | | Sold All | -4,100 | -100 % | | | | 5.53 % | $-3,649 | | | | | | News Article | History of Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Intrepid Mid Cap Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund | Health/Biotech | 10 | No Change | 0 | 0 % | | $170 | | - % | | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Managers Amg Funds - Timessquare Small Cap Growth Fund | Small-Cap Growth | 295,000 | Sold Some | -5,000 | -1.66 % | | $5,006,150 | | - % | | | | | | | News Article | History of Managers Amg Funds - Timessquare Small Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc - Capital Growth Portfolio | Multi-Cap Growth | | Sold All | -26,435 | -100 % | | | | - % | | | | | | | News Article | History of Ohio National Fund Inc - Capital Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Large-Cap Growth Index Portfolio | No Data | 268 | No Compare | | | | $4,548 | | - % | | | | | | | News Article | History of Pacific Select Fund - Pd Large-Cap Growth Index Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -1,527,529 | -100 % | | | | - % | | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Lazard Mid Cap Portfolio | Mid-Cap Core | 191,000 | Added More | 38,000 | 24.83 % | $3,067,460 | $3,241,270 | $173,810 | 5.66 % | $34,580 | | | | | | News Article | History of Met Investors Series Trust - Lazard Mid Cap Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Metaim Small Cap Growth Portfolio | Small-Cap Growth | 376,826 | Added More | 75,589 | 25.09 % | $6,051,826 | $6,394,737 | $342,912 | 5.66 % | $68,786 | | | | | | News Article | History of Met Investors Series Trust - Metaim Small Cap Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 2,483,123 | Sold Some | -3,334,005 | -57.31 % | $39,655,474 | $42,138,597 | $2,483,123 | 6.26 % | $-3,334,005 | | | | | | News Article | History of Amvescap Plc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | N-CSR | Crm Mutual Fund Trust - Crm All Cap Value Fund | Multi-Cap Value | 8,200 | Sold Some | -300 | -3.52 % | $130,954 | $139,154 | $8,200 | 6.26 % | $-300 | | | | | | News Article | History of Crm Mutual Fund Trust - Crm All Cap Value Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | N-CSR | Crm Mutual Fund Trust - Crm Mid Cap Value Fund | Mid-Cap Value | 272,800 | Added More | 39,800 | 17.08 % | $4,356,616 | $4,629,416 | $272,800 | 6.26 % | $39,800 | | | | | | News Article | History of Crm Mutual Fund Trust - Crm Mid Cap Value Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | N-CSR | Crm Mutual Fund Trust - Crm Small Cap Value Fund | Small-Cap Value | 477,100 | Added More | 5,700 | 1.20 % | $7,619,287 | $8,096,387 | $477,100 | 6.26 % | $5,700 | | | | | | News Article | History of Crm Mutual Fund Trust - Crm Small Cap Value Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 4,928,691 | Sold Some | -1,137,930 | -18.75 % | $78,711,195 | $83,639,886 | $4,928,691 | 6.26 % | $-1,137,930 | | | | | | News Article | History of Fmr Corp Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | N-CSR | Munder Series Trust - Munder Asset Allocation Fund Balanced | Flexible Portfolio | | Sold All | -28,000 | -100 % | | | | 6.26 % | $-28,000 | | | | | | News Article | History of Munder Series Trust - Munder Asset Allocation Fund Balanced Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | N-CSR | Munder Series Trust - Munder Energy Fund | Specialty & Misc | | Sold All | -2,603,925 | -100 % | | | | 6.26 % | $-2,603,925 | | | | | | News Article | History of Munder Series Trust - Munder Energy Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Rs Investment Trust - Rs Diversified Growth Fund | Multi-Cap Growth | 192,730 | New Holding | 192,730 | 100 % | $3,077,898 | $3,270,628 | $192,730 | 6.26 % | $192,730 | | | | | | News Article | History of Rs Investment Trust - Rs Diversified Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Rs Investment Trust - Rs Smaller Company Growth Fund | Small-Cap Growth | 57,570 | New Holding | 57,570 | 100 % | $919,393 | $976,963 | $57,570 | 6.26 % | $57,570 | | | | | | News Article | History of Rs Investment Trust - Rs Smaller Company Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Central Investment Portfolios Llc - Fidelity Health Care | Health/Biotech | 312,971 | New Holding | 312,971 | 100 % | $5,154,632 | $5,311,118 | $156,486 | 3.03 % | $156,486 | | | | | | News Article | History of Fidelity Central Investment Portfolios Llc - Fidelity Health Care Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Magellan Fund - Fidelity Magellan Fund | Large-Cap Growth | | Sold All | -4,000,000 | -100 % | | | | 3.03 % | $-2,000,000 | | | | | | News Article | History of Fidelity Magellan Fund - Fidelity Magellan Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -230 | -100 % | | | | 3.03 % | $-115 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Money Market Fund | Specialty & Misc | 24,400 | Sold Some | -900 | -3.55 % | $401,868 | $414,068 | $12,200 | 3.03 % | $-450 | | | | | | News Article | History of Usaa Mutual Funds Trust - Money Market Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Midcap Earnings Fund | Mid-Cap Core | 107 | No Change | 0 | 0 % | $1,762 | $1,816 | $54 | 3.03 % | $0 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Midcap Earnings Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Occ Value | Large-Cap Value | 432,753 | Sold Some | -243,900 | -36.04 % | $7,127,442 | $7,343,818 | $216,377 | 3.03 % | $-121,950 | | | | | | News Article | History of Allianz Funds - Occ Value Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Dws Variable Series Ii - Dws Balanced Vip | Flexible Portfolio | 2,500 | New Holding | 2,500 | 100 % | $41,175 | $42,425 | $1,250 | 3.03 % | $1,250 | | | | | | News Article | History of Dws Variable Series Ii - Dws Balanced Vip Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Dws Variable Series Ii - Dws Mid Cap Growth Vip | Mid-Cap Growth | 7,300 | Sold Some | -300 | -3.94 % | $120,231 | $123,881 | $3,650 | 3.03 % | $-150 | | | | | | News Article | History of Dws Variable Series Ii - Dws Mid Cap Growth Vip Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Dws Variable Series Ii - Dws Small Cap Growth Vip | Small-Cap Growth | 27,800 | Added More | 1,500 | 5.70 % | $457,866 | $471,766 | $13,900 | 3.03 % | $750 | | | | | | News Article | History of Dws Variable Series Ii - Dws Small Cap Growth Vip Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Evergreen Equity Trust De - Evergreen Growth Fund | Multi-Cap Growth | | Sold All | -10,003 | -100 % | | | | 3.03 % | $-5,002 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 1,053,867 | Sold Some | -68,706 | -6.12 % | $17,357,189 | $17,884,123 | $526,934 | 3.03 % | $-34,353 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Growth Index Fund | Multi-Cap Growth | 204,183 | Added More | 3,485 | 1.73 % | $3,362,894 | $3,464,986 | $102,092 | 3.03 % | $1,743 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Growth Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Index Fund | Specialty & Misc | 47,916 | Sold Some | -378 | -0.78 % | $789,177 | $813,135 | $23,958 | 3.03 % | $-189 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 6,144 | Sold Some | -672 | -9.85 % | $101,192 | $104,264 | $3,072 | 3.03 % | $-336 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 27,123 | Added More | 1,560 | 6.10 % | $446,716 | $460,277 | $13,562 | 3.03 % | $780 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Growth Index Fund | Mid-Cap Growth | 171,652 | Added More | 25,298 | 17.28 % | $2,827,108 | $2,912,934 | $85,826 | 3.03 % | $12,649 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Growth Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Index Fund | Mid-Cap Core | 150,469 | Sold Some | -10,016 | -6.24 % | $2,478,224 | $2,553,459 | $75,235 | 3.03 % | $-5,008 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Phoenix Aberdeen Worldwide Opportunities Fund - Virtus Small-Cap Growth Fund | No Data | 40,400 | New Holding | 40,400 | 100 % | $665,388 | $685,588 | $20,200 | 3.03 % | $20,200 | | | | | | News Article | History of Phoenix Aberdeen Worldwide Opportunities Fund - Virtus Small-Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Pioneer Series Trust Ii - Pioneer Growth Opportunities Fund | Multi-Cap Growth | | Sold All | -126,100 | -100 % | | | | 3.03 % | $-63,050 | | | | | | News Article | History of Pioneer Series Trust Ii - Pioneer Growth Opportunities Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Pioneer Variable Contracts Trust Ma - Pioneer Growth Opportunities Vct Portfolio | Multi-Cap Growth | | Sold All | -60,700 | -100 % | | | | 3.03 % | $-30,350 | | | | | | News Article | History of Pioneer Variable Contracts Trust Ma - Pioneer Growth Opportunities Vct Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Mid Cap Growth Portfolio | Mid-Cap Growth | 4,936 | New Holding | 4,936 | 100 % | $81,296 | $83,764 | $2,468 | 3.03 % | $2,468 | | | | | | News Article | History of Seasons Series Trust - Mid Cap Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sunamerica Equity Funds - New Century | Flexible Portfolio | | Sold All | -34,200 | -100 % | | | | 3.03 % | $-17,100 | | | | | | News Article | History of Sunamerica Equity Funds - New Century Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 597,230 | Added More | 252,631 | 73.31 % | $9,836,378 | $10,134,993 | $298,615 | 3.03 % | $126,316 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Fenway Funds - Vanguard Growth Equity Fund | Large-Cap Growth | | Sold All | -204,640 | -100 % | | | | 3.03 % | $-102,320 | | | | | | News Article | History of Vanguard Fenway Funds - Vanguard Growth Equity Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Capital Opportunity Fund | Specialty & Misc | | Sold All | -4,670,500 | -100 % | | | | 3.03 % | $-2,335,250 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Capital Opportunity Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Equity Fund | Specialty & Misc | | Sold All | -55,600 | -100 % | | | | 3.03 % | $-27,800 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Equity Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund | Small-Cap Core | | Sold All | -15,546 | -100 % | | | | 3.03 % | $-7,773 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Dws Advisor Funds - Dws Lifecycle Long Range Fund | Mixed-Asset Target Allocation Moderate | 4,000 | New Holding | 4,000 | 100 % | $64,280 | $67,880 | $3,600 | 5.60 % | $3,600 | | | | | | News Article | History of Dws Advisor Funds - Dws Lifecycle Long Range Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Dws Advisor Funds - Dws Mid Cap Growth Fund | Mid-Cap Growth | 137,800 | Added More | 84,800 | 160.00 % | $2,214,446 | $2,338,466 | $124,020 | 5.60 % | $76,320 | | | | | | News Article | History of Dws Advisor Funds - Dws Mid Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Dws Advisor Funds - Dws Small Cap Growth Fund | Small-Cap Growth | 29,500 | New Holding | 29,500 | 100 % | $474,065 | $500,615 | $26,550 | 5.60 % | $26,550 | | | | | | News Article | History of Dws Advisor Funds - Dws Small Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Ivy Funds Inc - Ivy Capital Appreciation Fund | Large-Cap Growth | | Sold All | -140 | -100 % | | | | 5.60 % | $-126 | | | | | | News Article | History of Ivy Funds Inc - Ivy Capital Appreciation Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Global Life Sciences Portfolio | Science & Tech | | Sold All | -4,473 | -100 % | | | | 5.60 % | $-4,026 | | | | | | News Article | History of Janus Aspen Series - Global Life Sciences Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-CSR | Sit Mutual Funds Inc - Sit Small Cap Growth Fund | Mid-Cap Growth | 13,700 | No Change | 0 | 0 % | $220,159 | $232,489 | $12,330 | 5.60 % | $0 | | | | | | News Article | History of Sit Mutual Funds Inc - Sit Small Cap Growth Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 608,273 | New Holding | 608,273 | 100 % | $9,774,947 | $10,322,393 | $547,446 | 5.60 % | $547,446 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 770,768 | New Holding | 770,768 | 100 % | $12,386,242 | $13,079,933 | $693,691 | 5.60 % | $693,691 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 927,206 | New Holding | 927,206 | 100 % | $14,900,200 | $15,734,686 | $834,485 | 5.60 % | $834,485 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 37,200 | Sold Some | -100 | -0.26 % | $597,804 | $631,284 | $33,480 | 5.60 % | $-90 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 47,205 | Added More | 9,905 | 26.55 % | $758,584 | $801,069 | $42,485 | 5.60 % | $8,915 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-26 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 340,000 | New Holding | 340,000 | 100 % | $5,429,800 | $5,769,800 | $340,000 | 6.26 % | $340,000 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-26 | 2009-06-30 | N-CSRS | M Fund Inc - Frontier Capital Appreciation Fund | Specialty & Misc | 40,800 | No Change | 0 | 0 % | $651,576 | $692,376 | $40,800 | 6.26 % | $0 | | | | | | News Article | History of M Fund Inc - Frontier Capital Appreciation Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Wisconsin Capital Funds Inc - Plumb Equity Fund | Specialty & Misc | 10,000 | New Holding | 10,000 | 100 % | $159,700 | $169,700 | $10,000 | 6.26 % | $10,000 | | | | | | News Article | History of Wisconsin Capital Funds Inc - Plumb Equity Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR | Integral Capital Management Vii Llc | Institution | 400,000 | No Change | 0 | 0 % | $6,324,000 | $6,788,000 | $464,000 | 7.33 % | $0 | | | | | | News Article | History of Integral Capital Management Vii Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR | Integral Capital Management Viii Llc | Institution | 225,000 | No Change | 0 | 0 % | $3,557,250 | $3,818,250 | $261,000 | 7.33 % | $0 | | | | | | News Article | History of Integral Capital Management Viii Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Jefferies Group Inc | Institution | | Sold All | -24,753 | -100 % | | | | 7.33 % | $-28,713 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR | Johnson Investment Counsel Inc | Institution | | Sold All | -15,500 | -100 % | | | | 7.33 % | $-17,980 | | | | | | News Article | History of Johnson Investment Counsel Inc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio | No Data | 72,000 | Added More | 8,600 | 13.56 % | $1,138,320 | $1,221,840 | $83,520 | 7.33 % | $9,976 | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust - The Boston Company International Small Cap Fund | Small-Cap Core | | Sold All | -58,243 | -100 % | | | | 6.79 % | $-62,902 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust - The Boston Company International Small Cap Fund Ownership Of Biomarin Pharmaceutical Inc |
RSS feed for BMRN